Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharlene Helene C See

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pathology, Research and Practice|January 6, 2022
Pathologic evaluation of specimens after neoadjuvant chemotherapy in breast cancer: Current recommendations and challengesSharlene Helene C See, Kalliopi P Siziopikou
Pathology, Research and Practice|August 23, 2020
The diagnostic utility of PRAME and p16 in distinguishing nodal nevi from nodal metastatic melanomaSharlene Helene C See, Brian S Finkelman, Anjana V Yeldandi
The American Journal of Dermatopathology|August 25, 2023
Sarcoidal Granuloma Annulare-Like Dermatitis and Vasculitis With Granulomatous Features: An Atypical Case of Giant Cell ArteritisYae Kye, Molly Hales, Sharlene Helene C See, et al.
Journal of Cutaneous Pathology|September 12, 2018
Distinguishing histopathologic features of acantholytic dermatoses and the pattern of acantholytic hypergranulosisSharlene Helene C See, Sandra Peternel, Derrick Adams, et al.
International Journal of Surgical Pathology|March 28, 2019
Ovarian Carcinosarcoma and Concurrent Serous Tubal Intraepithelial Carcinoma With Next-Generation Sequencing Suggesting an Origin From the Fallopian TubeSharlene Helene C See, Amir Behdad, Kruti P Maniar, et al.
The American Journal of Dermatopathology|December 10, 2020
Vulvar Elastosis: A Novel Diagnostic EntitySharlene Helene C See, Timothy L Tan, Traci A Kurtzer, et al.
Journal of Cutaneous Pathology|August 22, 2023
NONO::TFE3 fusion cutaneous epithelioid and spindle cell tumor: A case seriesSharlene Helene C See, Shantel Olivares, Maansi Kulkarni, et al.
Pathology, Research and Practice|January 5, 2023
The role of PRAME and NY-ESO-1 as potential therapeutic and prognostic biomarkers in triple-negative breast carcinomasSharlene Helene C See, Steven H Smith, Brian S Finkelman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pathology, Research and Practice|January 6, 2022
Pathologic evaluation of specimens after neoadjuvant chemotherapy in breast cancer: Current recommendations and challengesSharlene Helene C See, Kalliopi P Siziopikou
Pathology, Research and Practice|August 23, 2020
The diagnostic utility of PRAME and p16 in distinguishing nodal nevi from nodal metastatic melanomaSharlene Helene C See, Brian S Finkelman, Anjana V Yeldandi
The American Journal of Dermatopathology|August 25, 2023
Sarcoidal Granuloma Annulare-Like Dermatitis and Vasculitis With Granulomatous Features: An Atypical Case of Giant Cell ArteritisYae Kye, Molly Hales, Sharlene Helene C See, et al.
Journal of Cutaneous Pathology|September 12, 2018
Distinguishing histopathologic features of acantholytic dermatoses and the pattern of acantholytic hypergranulosisSharlene Helene C See, Sandra Peternel, Derrick Adams, et al.
International Journal of Surgical Pathology|March 28, 2019
Ovarian Carcinosarcoma and Concurrent Serous Tubal Intraepithelial Carcinoma With Next-Generation Sequencing Suggesting an Origin From the Fallopian TubeSharlene Helene C See, Amir Behdad, Kruti P Maniar, et al.
The American Journal of Dermatopathology|December 10, 2020
Vulvar Elastosis: A Novel Diagnostic EntitySharlene Helene C See, Timothy L Tan, Traci A Kurtzer, et al.
Journal of Cutaneous Pathology|August 22, 2023
NONO::TFE3 fusion cutaneous epithelioid and spindle cell tumor: A case seriesSharlene Helene C See, Shantel Olivares, Maansi Kulkarni, et al.
Pathology, Research and Practice|January 5, 2023
The role of PRAME and NY-ESO-1 as potential therapeutic and prognostic biomarkers in triple-negative breast carcinomasSharlene Helene C See, Steven H Smith, Brian S Finkelman, et al.
Pageof 1